New Cancer Grand Challenge projects 16 Jun 2022 Cambridge researchers to receive nearly £4M to tackle cancer roadblocks. Read more »
Shedding light on chromosomal instability 15 Jun 2022 Tumour ‘signatures’ could allow scientists to provide more accurate treatment for deadliest cancers. Read more »
New findings could change the way we think about DCIS in the clinic 9 Jun 2022 Cambridge researchers are part of an international team studying ductal carcinoma in situ (DCIS), a non-invasive breast lesion. Read more »
Research reveals how genetic mutations cause kidney cancer 8 Jun 2022 A study has identified how common genetic alterations lead to the development of kidney cancer. Read more »
Queen's Jubilee Birthday Honours 2 Jun 2022 Many congratulations to Professor Rebecca Fitzgerald for being awarded an OBE in the 2022 Queen's Jubilee Birthday Honours List. Read more »
Cambridge designated a Centre of Excellence for brain cancer care 27 May 2022 Addenbrooke’s hospital is part of six NHS brain cancer centres to be awarded excellence status by the Tessa Jowell Brain Cancer Mission. Read more »
Using artificial intelligence to find skin cancer earlier: the technology is not yet ready for use in primary care 25 May 2022 Artificial Intelligence (AI) aimed at detecting skin cancer is not yet ready for use in primary care settings, due to a lack of evidence in settings where the prevalence of skin cancer is low, according to CanTest researchers. Read more »
2022 Society of Memorial Sloan Kettering Prize 18 May 2022 Congratulations to Centre Director Prof Richard Gilbertson on being honoured for his impactful research on childhood brain tumours. Read more »
Fellows elected to Academy of Medical Sciences 2022 11 May 2022 Congratulations to three Centre members elected to the Fellowship of the Academy of Medical Sciences. Read more »
Nine Cambridge scientists among the new Fellows announced today by the Royal Society 10 May 2022 New Fellows include Centre Director Professor Richard Gilbertson and Centre members Profs Doug Easton and Paul Lehner. Read more »